secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lineage Cell Therapeutics, Inc. (LCTX)
CIK:        0000876343
Form:       8-K
Filed at:   2024-06-14T23:59:59+00:00
Accession:  0000950170-24-073769
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lineage Cell Therapeutics dismisses Withum, appoints Moss Adams as auditor
--------------------------------------------------------------------------

- Audit committee dismissed WithumSmith+Brown effective June 11, 2024.
- Engaged Moss Adams as independent auditor for fiscal year ending Dec 31, 2024.
- No disagreements or reportable events with former auditor in past two years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/876343/000095017024073769/0000950170-24-073769-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/876343/000095017024073769/lctx-20240614.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-073769

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer